Insider Transactions in Q2 2023 at Immuno Gen, Inc. (IMGN)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Stuart A Arbuckle Director |
BUY
Grant, award, or other acquisition
|
Direct |
695
+14.46%
|
$12,510
$18.87 P/Share
|
|
Jun 30
2023
|
Renee Lentini VP & PRIN ACCTG OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
3,195
+12.27%
|
$12,780
$4.05 P/Share
|
|
Jun 30
2023
|
Stacy Ann Coen SVP & CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
3,792
+25.71%
|
$15,168
$4.05 P/Share
|
|
Jun 30
2023
|
Anna Berkenblit SVP & CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
3,264
+2.79%
|
$13,056
$4.05 P/Share
|
|
Jun 30
2023
|
Theresa Wingrove SVP OF REGULATORY AFFAIRS |
BUY
Grant, award, or other acquisition
|
Direct |
2,811
+3.16%
|
$11,244
$4.05 P/Share
|
|
Jun 30
2023
|
Mark J Enyedy CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
5,241
+1.17%
|
$20,964
$4.05 P/Share
|
|
Jun 30
2023
|
Helen M. Thackray Director |
BUY
Grant, award, or other acquisition
|
Direct |
397
+14.45%
|
$7,146
$18.87 P/Share
|
|
Jun 30
2023
|
Mark Alan Goldberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
894
+1.49%
|
$16,092
$18.87 P/Share
|